Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia.
about
Neonatal thrombocytopenia: causes and managementNeonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases.Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland.A novel method for simultaneous analysis of specific platelet antibodies: SASPA.Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization.Advances in the management of alloimmune thrombocytopenia.Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.Evaluation and management of postpartum hemorrhage: consensus from an international expert panel.Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop.Expression of a single-chain human leukocyte antigen-DRA/DRB3*01:01 molecule and differential binding of a monoclonal antibody in the presence of specifically bound human platelet antigen-1a peptide.
P2860
Q24673677-2EF3D1D0-F416-4F52-8F64-680487108646Q33341730-1179E3C2-2216-4C14-85E1-3E7332088758Q33347954-42C60C5B-C7DF-438F-9B91-14BCD6AB98A7Q33363850-DF61A3C0-03C8-47C5-8860-7C6235FB400DQ33363893-07FFF7C5-65EC-4FBC-83B0-8A9FE522C6DBQ33373910-D89E3C36-2D8C-45A5-A720-F3ACE21E0955Q33375062-3C7CEB7B-4EF6-4EA3-9443-C13EF3C38BCDQ33375634-FBE1AC50-689A-4A98-80AA-7DE8E7952A2AQ33380492-D6FF0EF0-11A0-45A7-985B-0D9BE382E646Q38195090-5FCADA5A-8BD8-4BA0-9635-DE36051B86EEQ53298578-F2D00175-2F03-4007-B36A-BA8772BF42F0Q54486514-8C9862A4-B4DC-4E08-AE7F-87BAEC197C58
P2860
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Provision of platelet support ...... l alloimmune thrombocytopenia.
@ast
Provision of platelet support ...... l alloimmune thrombocytopenia.
@en
Provision of platelet support ...... l alloimmune thrombocytopenia.
@nl
type
label
Provision of platelet support ...... l alloimmune thrombocytopenia.
@ast
Provision of platelet support ...... l alloimmune thrombocytopenia.
@en
Provision of platelet support ...... l alloimmune thrombocytopenia.
@nl
prefLabel
Provision of platelet support ...... l alloimmune thrombocytopenia.
@ast
Provision of platelet support ...... l alloimmune thrombocytopenia.
@en
Provision of platelet support ...... l alloimmune thrombocytopenia.
@nl
P2093
P2860
P1476
Provision of platelet support ...... l alloimmune thrombocytopenia.
@en
P2093
Campbell K
Ouwehand WH
Ranasinghe E
P2860
P356
10.1046/J.1365-2141.2001.02703.X
P407
P577
2001-04-01T00:00:00Z